You have read all your free articles, to continue reading subscribe to read the rest of this content.
Targovax has announced the first set of clinical results from the randomized phase I/II trial of ONCOS-102 in combination with standard of care chemotherapy in malignant pleural mesothelioma (MPM). The trial is an open label, exploratory phase I/II adding ONCOS-102 to standard of care (SoC) chemoAlready a subscriber Login You…
A team of scientists from San Francisco has found a way to transport medication to fight Alzheimer’s disease through the blood-brain barrier in monkeys without serious side-effects. A Danish PhD student who is participating on the research team, Maria Selch Hersom, from the Department of PharmaAlready a subscriber Login You…
Bavarian Nordic has announced the dosing of the first subject in the Phase 3 VANIR clinical trial of its investigational respiratory syncytial virus (RSV) vaccine candidate, MVA-BN RSV in older adults. The VANIR trial is a global, randomized, double-blind Phase 3 trial of the recombinant MVA-BN RAlready a subscriber Login…
Data from the phase 3 OCEAN study, evaluating the efficacy and safety of melflufen plus dexamethasone versus pomalidomide plus dexamethasone in lenalidomide refractory patients with relapsed refractory multiple myeloma that have received 2-4 prior lines of therapy, have been published in the Lancet Already a subscriber Login You have read…
